Search Results

There are 9218 results for: content related to: Celecoxib-Induced Erythema Multiforme with Glyburide Cross-Reactivity

  1. Greater reductions in A1C in type 2 diabetic patients new to therapy with glyburide/metformin tablets as compared to glyburide co-administered with metformin

    Diabetes, Obesity and Metabolism

    Volume 5, Issue 6, November 2003, Pages: 424–431, L. Blonde, J. Wogen, C. Kreilick and A. A. Seymour

    Version of Record online : 6 NOV 2003, DOI: 10.1046/j.1463-1326.2003.00297.x

  2. Glyburide: A Second-generation Sulfonylurea Hypoglycemic Agent

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 5, Issue 2, March-April 1985, Pages: 43–62, Jerome M. Feldman

    Version of Record online : 24 JAN 2012, DOI: 10.1002/j.1875-9114.1985.tb03404.x

  3. Development of a glyburide-metformin fixed combination tablet with optimized glyburide particle size

    Drug Development Research

    Volume 66, Issue 1, September 2005, Pages: 25–35, Peter Timmins, Punit H. Marathe, Gill Cave, Mark E. Arnold, Andrew B. Dennis and Douglas S. Greene

    Version of Record online : 24 JAN 2006, DOI: 10.1002/ddr.20035

  4. N-succinylaspart-1-yl celecoxib is a potential colon-specific prodrug of celecoxib with improved therapeutic properties

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 5, May 2012, Pages: 1831–1842, Yonghyun Lee, Jeongyun Kim, Hyunjeong Kim, Sookjin Kang, Jeong-Hyun Yoon, Dae-Duk Kim, Young Mi Kim and Yunjin Jung

    Version of Record online : 14 FEB 2012, DOI: 10.1002/jps.23082

  5. Elucidating Rifampin's Inducing and Inhibiting Effects on Glyburide Pharmacokinetics and Blood Glucose in Healthy Volunteers: Unmasking the Differential Effects of Enzyme Induction and Transporter Inhibition for a Drug and Its Primary Metabolite

    Clinical Pharmacology & Therapeutics

    Volume 85, Issue 1, January 2009, Pages: 78–85, HX Zheng, Y Huang, LA Frassetto and LZ Benet

    Version of Record online : 8 OCT 2008, DOI: 10.1038/clpt.2008.186

  6. You have free access to this content
    Pharmacoepidemiologic and in vitro evaluation of potential drug–drug interactions of sulfonylureas with fibrates and statins

    British Journal of Clinical Pharmacology

    Volume 78, Issue 3, September 2014, Pages: 639–648, H. Schelleman, X. Han, C. M. Brensinger, S. K. Quinney, W. B. Bilker, D. A. Flockhart, L. Li and Sean Hennessy

    Version of Record online : 21 AUG 2014, DOI: 10.1111/bcp.12353

  7. In vivo and in vitro studies exploring the pharmacokinetic interaction between bosentan, a dual endothelin receptor antagonist, and glyburide

    Clinical Pharmacology & Therapeutics

    Volume 71, Issue 4, April 2002, Pages: 253–262, Paul L. M. van Giersbergen, Alexander Treiber, Martine Clozel, Frédéric Bodin and Jasper Dingemanse

    Version of Record online : 18 APR 2002, DOI: 10.1067/mcp.2002.122473

  8. You have free access to this content
    Contribution of ATP-sensitive potassium channels to the electrophysiological effects of adenosine in guinea-pig atrial cells.

    The Journal of Physiology

    Volume 484, Issue 3, May 1, 1995, Pages: 629–642, G R Li, J Feng, A Shrier and S Nattel

    Version of Record online : 1 MAY 1995, DOI: 10.1113/jphysiol.1995.sp020692

  9. The metabolism of glyburide in subjects of known debrisoquin phenotype

    Clinical Pharmacology & Therapeutics

    Volume 45, Issue 3, March 1989, Pages: 277–284, G F Peart, J Boutagy and G M Shenfield

    Version of Record online : 28 MAR 1989, DOI: 10.1038/clpt.1989.28

  10. Glyburide Protein Binding and the Effect of Albumin Glycation in Children, Young Adults, and Older Adults with Diabetes

    The Journal of Clinical Pharmacology

    Volume 35, Issue 7, July 1995, Pages: 739–745, Dr. K. M. Olsen, Dr. G. L. Kearns and Dr. S. F. Kemp

    Version of Record online : 8 MAR 2013, DOI: 10.1002/j.1552-4604.1995.tb04115.x

  11. You have free access to this content
    American College of Clinical Pharmacy 2000 Spring Practice and Research Forum April 2–5, 2000

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 20, Issue 3, March 2000, Pages: 337–370,

    Version of Record online : 17 JAN 2012, DOI: 10.1592/phco.20.4.337.34884

  12. A system approach to pharmacodynamics II: Glyburide pharmacodynamics and estimation of optimal drug delivery

    Journal of Pharmaceutical Sciences

    Volume 77, Issue 1, January 1988, Pages: 48–55, William R. Gillespie, Peter Veng-Pedersen, Edward J. Antal and J. Paul Phillips

    Version of Record online : 17 SEP 2006, DOI: 10.1002/jps.2600770109

  13. You have free access to this content
    Sitagliptin, an dipeptidyl peptidase-4 inhibitor, does not alter the pharmacokinetics of the sulphonylurea, glyburide, in healthy subjects

    British Journal of Clinical Pharmacology

    Volume 66, Issue 1, July 2008, Pages: 36–42, Goutam C. Mistry, Arthur J. Bergman, Wei Zheng, David Hreniuk, Miguel A. Zinny, Keith M. Gottesdiener, John A. Wagner, Gary A. Herman and Marcella Ruddy

    Version of Record online : 22 MAY 2008, DOI: 10.1111/j.1365-2125.2008.03148.x

  14. Coadministration of glyburide and minoxidil, drugs with opposing effects on potassium channels

    Clinical Pharmacology & Therapeutics

    Volume 61, Issue 6, June 1997, Pages: 662–668, C. Michael Stein, Nancy Brown, Michael G. Carlson, Peter Campbell and Alastair J. J. Wood

    Version of Record online : 19 JUN 1997, DOI: 10.1016/S0009-9236(97)90101-6

  15. You have free access to this content
    Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib

    American Journal of Hematology

    Volume 81, Issue 4, April 2006, Pages: 242–255, Guang-Sen Zhang, Ding-Sheng Liu, Chong-Wen Dai and Rui-Juan Li

    Version of Record online : 20 MAR 2006, DOI: 10.1002/ajh.20542

  16. Risk of acute coronary events associated with glyburide compared with gliclazide use in patients with type 2 diabetes: a nested case–control study

    Diabetes, Obesity and Metabolism

    Volume 16, Issue 1, January 2014, Pages: 22–29, A. S. Abdelmoneim, D. T. Eurich, J. M. Gamble, J. A. Johnson, J. M. Seubert, W. Qiu and S. H. Simpson

    Version of Record online : 19 JUL 2013, DOI: 10.1111/dom.12173

  17. Nateglinide provides tighter glycaemic control than glyburide in patients with Type 2 diabetes with prevalent postprandial hyperglycaemia

    Diabetic Medicine

    Volume 28, Issue 5, May 2011, Pages: 560–566, A. Bellomo Damato, G. Stefanelli, L. Laviola, R. Giorgino and F. Giorgino

    Version of Record online : 12 APR 2011, DOI: 10.1111/j.1464-5491.2010.03219.x

  18. Impact of CYP2C9 amino acid polymorphisms on glyburide kinetics and on the insulin and glucose response in healthy volunteers

    Clinical Pharmacology & Therapeutics

    Volume 71, Issue 4, April 2002, Pages: 286–296, Julia Kirchheiner, Jürgen Brockmöller, Ingolf Meineke, Steffen Bauer, Wolfgang Rohde, Christian Meisel and Ivar Roots

    Version of Record online : 18 APR 2002, DOI: 10.1067/mcp.2002.122476

  19. Improving glyburide solubility and dissolution by complexation with hydroxybutenyl-β-cyclodextrin

    Journal of Pharmacy and Pharmacology

    Volume 61, Issue 1, January 2009, Pages: 23–30, Sandra Klein, Michael F. Wempe, Thomas Zoeller, Norma L. Buchanan, Juanelle L. Lambert, Michael G. Ramsey, Kevin J. Edgar and Charles M. Buchanan

    Version of Record online : 8 JAN 2010, DOI: 10.1211/jpp.61.01.0004

  20. Long-term Safety of Pioglitazone versus Glyburide in Patients with Recently Diagnosed Type 2 Diabetes Mellitus

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 26, Issue 10, October 2006, Pages: 1388–1395, Dr. Rajeev Jain, Dr. Kwame Osei, Dr. Stuart Kupfer, Dr. Alfonso T. Perez, Mr. Jeff Zhang and Mary-Margaret Lannon

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.26.10.1388